Cited by 4Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Use of fasting plasma glucose to determine the approach for diagnosing gestational diabetes mellitus

Open access
Metzger, Boyd E., Kuang, Alan, Lowe, William L., Scholtens, Denise M., Lowe, Lynn P., Dyer, Alan R.·2023·Diabetes Research and Clinical Practice

Abstract

Aims Estimate the impact of OGTTs only on women with a screening FPG of 4.5-5.0 mmol/L using data from HAPO. Methods HAPO participants had 75-g OGTTs (24-32 weeks' gestation). At follow-up, children had adiposity assessed (overweight/obesity, obesity) and mothers and children had OGTTs. GDM was defined retrospectively using IADPSG criteria. Odds for neonatal (birthweight, percent neonatal fat, sum of skinfolds, cord C-peptide > 90th percentiles) and follow-up outcomes were assessed in those with HAPO FPG ≤ 4.4 or > 4.4 mmol/L and GDM or no GDM focusing on women with FPG > 4.4 and no GDM (Group 3) vs women with GDM and FPG ≤ 4.4 (Group 2). Results This strategy would miss a diagnosis of GDM in 14.7%. Odds for neonatal outcomes in Groups 2 and 3 were not different (ORs: 1.14 to 1.29). Odds at follow-up for type 2 diabetes and disorders of glucose metabolism in mothers were higher in Group 2 (ORs: 3.51, 2.57). Odds for childhood impaired glucose tolerance or adiposity outcomes were not different for Groups 2 and 3. Conclusions HAPO mothers whose GDM diagnosis would be missed were not at greater risk for adverse neonatal and childhood outcomes than mothers with FPG of 4.5-5.0 without GDM.

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2023.110952

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Further analysis from HAPO showed that women with FPG ≤ 4.4 mmol/L but meeting the one-hour or two-hour glucose criteria for gestational diabetes mellitus, compared with women with FPG > 4.4 mmol/L who did not meet any IADPSG glucose thresholds for gestational diabetes mellitus, had children with similar neonatal outcomes, childhood impaired glucose tolerance, and adiposity.

    “Further analysis from HAPO showed that women with FPG ≤ 4.4 mmol/L but meeting the one‐hour or two‐hour glucose criteria for gestational diabetes mellitus, compared with women with FPG > 4.4 mmol/L who did not meet any IADPSG glucose thresholds for gestational diabetes mellitus, had children with similar neonatal outcomes, childhood impaired glucose tolerance, and adiposity.”
  • Women with FPG ≤ 4.4 mmol/L but meeting the one-hour or two-hour glucose criteria for gestational diabetes mellitus had higher rates of type 2 diabetes at ten to 14 years' follow-up (aOR, 3.51; 95% CI, 1.41-8.75) compared with women with FPG > 4.4 mmol/L who did not meet any IADPSG glucose thresholds.

    “However, women in the former group had higher rates of type 2 diabetes at ten to 14 years’ follow‐up (aOR, 3.51; 95% CI, 1.41–8.75). 34”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Metzger, B. E., Kuang, A., Lowe, W. L., Scholtens, D. M., Lowe, L. P., & Dyer, A. R.
Affiliations
Northwestern University (US)
Corresponding author
Metzger, Boyd E.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2023-11
Volume
205
Pages
110952
ISSN
0168-8227 (ISSN-L)
OpenAlex
W4387566275
Cited by
4
References
4
Citations by year
2026: 1 · 2025: 3
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences (UL1TR001422)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (1U01DK094830, R01-HD-34243, R01-HD-34242)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, fasting blood glucose, oral glucose tolerance test, GDM screening, missed diagnosis, neonatal outcomes, childhood adiposity, type 2 diabetes risk, impaired glucose tolerance, HAPO study, IADPSG criteria
MeSH terms
Blood Glucose, Child, Diabetes Mellitus, Type 2, Fasting, Female, Humans, Infant, Newborn, Obesity, Pregnancy, Retrospective Studies, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review